These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16040047)

  • 1. Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum.
    Guo CY; Li ZY; Xu MQ; Yuan JM
    J Immunol Methods; 2005 Aug; 303(1-2):142-7. PubMed ID: 16040047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
    Sun C; Meng F; Li Y; Jin Q; Li H; Li F
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):99-102. PubMed ID: 20196680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of recombinant acetylcholine receptor α subunit 1-211 in immunoadsorbent and DNA immunization.
    Niu L; Guo C; Hao Z; Yuan J; Li Z
    J Immunol Methods; 2011 Sep; 372(1-2):14-21. PubMed ID: 21787780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies.
    Hewer R; Matthews I; Chen S; McGrath V; Evans M; Roberts E; Nute S; Sanders J; Furmaniak J; Smith BR
    Clin Chim Acta; 2006 Feb; 364(1-2):159-66. PubMed ID: 16051208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy.
    Skriapa L; Zisimopoulou P; Trakas N; Grapsa E; Tzartos SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):150-8. PubMed ID: 25262156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.
    Sideris S; Lagoumintzis G; Kordas G; Kostelidou K; Sotiriadis A; Poulas K; Tzartos SJ
    J Neuroimmunol; 2007 Sep; 189(1-2):111-7. PubMed ID: 17617475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency.
    Kostelidou K; Trakas N; Tzartos SJ
    J Neuroimmunol; 2007 Oct; 190(1-2):44-52. PubMed ID: 17764755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis.
    Takamori M; Ide Y
    Transfus Sci; 1996 Sep; 17(3):445-53. PubMed ID: 10163553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific apheresis of autoantibodies in myasthenia gravis.
    Lazaridis K; Zisimopoulou P; Lagoumintzis G; Skriapa L; Trakas N; Evangelakou P; Kanelopoulos I; Grapsa E; Poulas K; Tzartos S
    Ann N Y Acad Sci; 2012 Dec; 1275():7-12. PubMed ID: 23278571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunoadsorbent for myasthenia gravis treatment: development of synthetic peptide designed to remove antiacetylcholine receptor antibody.
    Miyahara T; Oka K; Nakaji S
    Ther Apher; 1998 Aug; 2(3):246-8. PubMed ID: 10227779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
    Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
    J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective removal of anti-acetylcholine receptor antibodies and IgG in vitro with an immunoadsorbent containing immobilized sulfathiazole.
    Yamamoto Y; Sameshima T; Akaike T
    Artif Organs; 1990 Oct; 14(5):334-41. PubMed ID: 2241600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor.
    Takamori M; Maruta T
    Ther Apher; 2001 Oct; 5(5):340-50. PubMed ID: 11778918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.